Skip to main content
OpenTrials

Clinical trial condition

Muscle-invasive Bladder Cancer

Explore clinical trials studying Muscle-invasive Bladder Cancer. Study availability and eligibility vary by location and protocol.

15 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Muscle-invasive Bladder Cancer trial results

Completed

Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging

NCT02462239

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Juravinski Cancer Centre Hamilton, Ontario, Canada
  • London Regional Cancer Centre London, Ontario, Canada
  • Ottawa Hospital Regional Cancer Centre Ottawa, Ontario, Canada
  • Thunder Bay Regional Health Sciences Centre Thunder Bay, Ontario, Canada
View Trial Details
Completed

A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

NCT04209114

Conditions
Bladder Cancer, Bladder Tumor, Female Urogenital Diseases, +11 more
Locations
  • Local Institution - 0080 Gilbert, Arizona, United States
  • Local Institution - 0136 Tucson, Arizona, United States
  • Local Institution - 0029 La Jolla, California, United States
  • Local Institution - 0015 Orange, California, United States
View all 116 locations
View Trial Details
Completed

Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

NCT00808639

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Lahey Clinic Burlington, Massachusetts, United States
  • University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

A Study to Compare Chemotherapy Alone Versus Chemotherapy Plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Therapy After Surgery With Nivolumab or Nivolumab and BMS-986205 in Participants With Muscle Invasive Bladder Cancer

NCT03661320

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Local Institution - 0022 Tucson, Arizona, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Local Institution - 0021 Littleton, Colorado, United States
  • Local Institution - 0036 Pensacola, Florida, United States
View all 172 locations
View Trial Details
Active, Not Recruiting

A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Participants With High-risk Muscle-invasive Bladder Cancer (MIBC) Who Are ctDNA Positive Following Cystectomy

NCT04660344

Conditions
Muscle-invasive Bladder Cancer
Locations
  • Cancer Care Centers of Brevard Rockledge, Florida, United States
  • Optum Health Care Las Vegas, Nevada, United States
  • Cleveland Clinic Cleveland, Ohio, United States
  • AHN Cancer Institute ? Allegheny General Hospital Pittsburgh, Pennsylvania, United States
View all 148 locations
View Trial Details

Related conditions